diabet
mellitu
grow
problem
part
world
clinic
trial
anim
model
type
type
ii
diabet
shown
hyperact
angiotensinii
angii
signal
pathway
contribut
develop
diabet
diabet
complic
clinic
relev
blockad
reninangiotensin
system
prevent
newonset
diabet
reduc
risk
diabet
complic
angiotensinconvert
enzym
ace
recent
discov
monocarboxypeptidas
first
homolog
ace
thought
inhibit
angii
signal
cascad
mostli
cleav
angii
gener
ang
effect
oppos
angii
mediat
ma
receptor
enzym
present
kidney
liver
adipos
tissu
pancrea
express
elev
endocrin
pancrea
diabet
earli
phase
diabet
nephropathi
hypothes
act
compensatori
manner
diabet
diabet
nephropathi
recent
shown
presenc
ma
receptor
mous
pancrea
observ
reduct
ma
receptor
immunoreact
well
higher
fast
blood
glucos
level
knockout
mice
indic
mice
may
new
model
studi
role
diabet
review
examin
role
reninangiotensin
system
physiopatholog
treatment
diabet
highlight
potenti
benefit
ma
receptor
axi
focus
recent
data
diabet
mellitu
character
insulin
insuffici
due
either
decreas
insulin
releas
endorgan
insulin
resist
sever
major
categori
diabet
exist
type
type
ii
diabet
gestat
diabet
matur
onset
diabet
young
modi
usual
occur
children
young
adult
character
pancreat
failur
autoimmun
destruct
pancreat
character
insulin
resist
rel
insulin
insuffici
adult
onset
risk
classic
reninangiotensin
system
consist
livergener
angiotensinogen
cleav
renin
gener
kidney
produc
angiotensini
angi
angi
subsequ
hydrolyz
angiotensinconvert
enzym
ace
produc
angiotensinii
angii
promot
vasoconstrict
inflamm
salt
water
reabsorpt
oxid
stress
two
decad
ago
concept
local
tissu
ra
introduc
follow
observ
mani
tissu
capabl
synthes
major
ra
compon
local
dzau
lavoi
sigmund
exist
local
ra
confirm
mani
tissu
includ
heart
danser
schalekamp
vasculatur
paul
et
al
brain
baltatu
et
al
retina
tikelli
et
al
liver
batal
et
al
paizi
et
al
pancrea
lau
et
al
local
ra
influenc
function
metabol
organ
develop
diabet
fig
express
ace
angii
type
receptor
renin
identifi
liver
quantit
rtpcr
paizi
et
al
protein
express
confirm
immunohistochemistri
paizi
et
al
angii
type
receptor
express
report
stellat
cell
batal
et
al
although
could
confirm
group
paizi
et
al
studi
involv
ra
blockad
set
diabet
given
clue
potenti
role
intrahepat
ra
pathogenesi
diabet
ra
blockad
prevent
hepat
triglycerid
accumul
obes
zucker
rat
common
featur
insulin
resist
diabet
state
toblli
et
al
addit
enalapril
prevent
fibrosi
oxid
stress
liver
heart
kidney
rat
de
cavanagh
et
al
remark
evid
role
ra
diabet
demonstr
captopril
suppress
hepat
glucos
output
increas
hepat
glucos
uptak
respons
insulin
infus
torlon
et
al
ra
compon
identifi
endocrin
exocrin
pancrea
angiotensinogen
renin
receptor
ace
protein
express
organ
tikelli
et
al
leung
et
al
chappel
et
al
carlsson
leung
et
al
addit
receptor
protein
express
limit
pancreat
tahmasebi
et
al
prorenin
mrna
express
identifi
situ
hybrid
reticular
fiber
islet
perivascular
connect
tissu
immunostain
reveal
islet
prorenin
protein
primarili
exist
tahmasebi
et
al
sever
studi
demonstr
activ
islet
ra
diabet
anim
leung
tikelli
et
al
mainten
islet
perfus
import
regul
glucosestimul
insulin
secret
gsi
tikelli
et
al
potenti
role
pancrea
ra
suggest
mainten
islet
blood
flow
leung
support
evid
includ
greater
angii
level
islet
microvessel
compar
exocrin
pancrea
microvessel
carlsson
et
al
acut
angii
infus
decreas
islet
blood
flow
healthi
nondiabet
spraguedawley
rat
carlsson
et
al
ra
blockad
ace
inhibitor
receptor
blocker
preferenti
increas
blood
flow
islet
microvessel
carlsson
et
al
anoth
role
islet
ra
modul
function
insulin
releas
occur
two
phase
first
phase
appear
within
min
stimulu
peak
min
curri
et
al
nondiabet
rat
acut
angii
infus
prevent
first
phase
insulin
secret
respons
glucos
carlsson
et
al
healthi
human
subject
pressor
dose
angii
suppress
basal
pulsatil
glucosestimul
insulin
releas
fliser
et
al
loss
first
phase
insulin
secret
hypothes
earliest
detect
defect
develop
gerich
although
ra
inhibit
effect
basal
insulin
secret
carlsson
et
al
may
improv
insulin
synthesi
secret
protect
oxid
stressrel
tissu
damag
loss
insulin
secret
pancreat
islet
express
lower
level
antioxid
major
tissu
bodi
grankvist
et
al
make
especi
vulner
oxid
stress
evan
et
al
sever
studi
indic
hyperglycemia
produc
reactiv
oxygen
speci
ro
islet
pancreat
wu
et
al
tsubouchi
et
al
tang
et
al
bindoka
et
al
illustr
diabet
zucker
rat
tang
et
al
moreov
oxid
stress
induc
pancreat
dysfunct
robertson
matsuoka
et
al
maechler
et
al
kaneto
et
al
harmon
et
al
nad
p
h
oxidas
nox
one
suggest
sourc
ro
islet
nakayama
et
al
oliveira
et
al
tsubouchi
et
al
nox
activ
trigger
interact
angii
receptor
griendl
et
al
requir
assembl
cytosol
subunit
membran
bound
scaffold
protein
harrison
et
al
express
oliveira
et
al
oliveira
et
al
uchizono
et
al
shown
pancreat
increas
model
nakayama
et
al
oliveira
et
al
tsubouchi
et
al
addit
caus
pancreat
dysfunct
apoptosi
oxid
stress
lead
loss
insulin
synthesi
secret
sever
mechan
includ
loss
transcript
factor
eg
mafa
requir
insulin
gene
express
matsuoka
et
al
kaneto
et
al
secondli
ro
implic
develop
amyloid
deposit
hayden
tyagi
islet
fibrosi
hayden
et
al
link
develop
dysfunct
apoptosi
clark
nilsson
hayden
et
al
agreement
hypothesi
ra
activ
lead
increas
islet
ro
fibrosi
hayden
et
al
demonstr
rat
elev
angii
accumul
due
renin
overexpress
langheinrich
et
al
elev
islet
nitrotyrosin
content
fibrosi
hayden
et
al
addit
islet
nitrotyrosin
express
coloc
area
increas
periislet
fibrosi
hayden
et
al
enhanc
fibrosi
islet
decreas
insulin
synthesi
cumul
caus
decreas
insulin
secret
exacerb
develop
diabet
ra
blockad
shown
effect
reduc
oxid
stressinduc
chang
islet
inhibit
express
nox
compon
nakayama
et
al
thu
decreas
express
oxid
stress
marker
includ
nitrotyrosin
lupi
et
al
tikelli
et
al
b
modifi
protein
marker
fatti
acid
oxid
nakayama
et
al
addit
ra
blockad
associ
decreas
islet
ace
express
tikelli
et
al
b
would
result
decreas
nox
activ
moreov
ra
blockademedi
decreas
express
nox
compon
shao
et
al
nitrotyrosin
level
shao
et
al
tikelli
et
al
islet
associ
prevent
islet
dysfunct
deleteri
chang
islet
morpholog
demonstr
prevent
islet
fibrosi
shao
et
al
tikelli
et
al
b
loss
insulin
secret
lupi
et
al
shao
et
al
tikelli
et
al
loss
reduct
islet
insulin
content
shao
et
al
tikelli
et
al
nakayama
et
al
independ
chang
plasma
glucos
level
therefor
hyperact
angii
signal
cascad
clearli
implic
develop
islet
oxid
stress
subsequ
dysfunct
clinic
trial
demonstr
abil
ra
blockad
prevent
newonset
diabet
develop
diabet
complic
metaanalysi
sever
trial
demonstr
ace
inhibitor
angii
receptor
blocker
arb
reduc
risk
diabet
abuissa
et
al
interestingli
compar
diuret
therapi
patient
receiv
arb
ace
inhibitor
lower
risk
develop
newonset
diabet
despit
similar
reduct
blood
pressur
bp
anonym
niklason
et
al
reid
et
al
verm
et
al
inde
therapi
shown
increas
risk
develop
diabet
mason
et
al
gress
et
al
find
indic
reduct
bp
alon
suffici
prevent
new
onset
diabet
effect
like
specif
ra
inhibit
addit
prevent
newonset
diabet
ra
blockad
amelior
glycem
control
diabet
patient
reduc
glycosyl
hemoglobin
hba
level
measur
longterm
glycem
control
anonym
yusuf
et
al
reduc
use
oral
antihyperglycem
agent
diabet
compar
placebo
convent
therapi
anonym
yusuf
et
al
abil
ra
blockad
prevent
newonset
diabet
amelior
glycem
control
diabet
patient
combin
abil
improv
islet
morpholog
insulin
secret
insulin
sensit
provid
power
evid
ra
continu
target
novel
therapeut
diabet
initi
identifi
human
heart
failur
lymphoma
cdna
librari
donoghu
et
al
tipni
et
al
later
shown
serv
receptor
sar
coronaviru
li
et
al
first
ace
homologu
sequenc
homolog
unlik
ace
zinc
metalloproteas
contain
one
hexxh
consensu
sequenc
result
monocarboxypeptidas
activ
tipni
et
al
addit
also
sequenc
homolog
collectrin
newli
discov
glycoprotein
respons
regul
renal
amino
acid
transport
danilczyk
et
al
zhang
et
al
mainten
collect
duct
cell
morpholog
zhang
et
al
protein
share
ident
cytosol
sheddas
transmembran
noncatalyt
extracellular
domain
zhang
et
al
exist
membran
bound
solubl
form
donoghu
et
al
feng
et
al
latter
gener
proteolyt
cleavag
ectodomain
tumor
necrosi
factor
convertas
lambert
et
al
although
share
catalyt
domain
ace
sensit
ace
inhibitor
tipni
et
al
substrat
specif
hypothes
requir
proxprohydrophobicbas
conform
proteolyt
cleavag
guy
et
al
carboxypeptidas
capabl
cleav
termin
leucin
angi
gener
ang
donoghu
et
al
approxim
greater
affin
angii
vicker
et
al
cleav
termin
phenylalanin
residu
angii
gener
ang
tipni
et
al
although
enzym
also
capabl
complet
hydrolysi
desarg
bradykinin
neocasomorphin
dynorphina
partial
hydrolysi
mani
biolog
activ
peptid
includ
neurotensin
ghrelin
vicker
et
al
effect
angiotensin
peptid
investig
far
sinc
origin
detect
primarili
human
heart
kidney
test
donoghu
et
al
identifi
varieti
tissu
includ
rat
brain
gallagh
et
al
lung
gembardt
et
al
adipos
tissu
gembardt
et
al
liver
paizi
et
al
pancrea
tikelli
et
al
retina
tikelli
et
al
human
placenta
et
al
colon
small
intestin
ovari
tipni
et
al
thought
ubiquit
express
hypothes
regul
ra
oppos
ace
receptor
axi
therefor
counter
sever
patholog
process
includ
cardiac
dysfunct
diezfreir
et
al
gurley
et
al
yamamoto
et
al
hypertens
diezfreir
et
al
gurley
et
al
yamazato
et
al
acut
respiratori
distress
syndrom
imai
et
al
imai
et
al
inflamm
huentelman
et
al
paizi
et
al
diezfreir
et
al
fibrosi
diezfreir
et
al
huentelman
et
al
paizi
et
al
herath
et
al
angii
well
known
vasoconstrictor
proinflammatori
prooxid
effect
mediat
mostli
receptor
ang
primari
product
angii
degrad
act
ma
receptor
santo
et
al
produc
vasodil
via
activ
bradykinin
nitric
oxid
oliveira
et
al
brosnihan
et
al
fernand
et
al
paula
et
al
toblli
et
al
releas
prostaglandin
almeida
et
al
inhibit
norepinephrin
releas
gironacci
et
al
recent
studi
implic
akt
pathway
ang
mediat
releas
sampaio
et
al
addit
attenu
fibrosi
inflamm
inhibit
grobe
et
al
macrophag
migrat
inhibitori
factor
mif
zhong
et
al
studi
context
diabet
essenti
focus
kidney
may
import
target
treatment
prevent
diabet
nephropathi
progress
condit
character
mesangi
matrix
expans
thicken
glomerular
basement
membran
proteinuria
associ
chronic
renal
failur
recent
sever
studi
also
implic
podocyt
loss
schmid
et
al
susztak
et
al
dalla
vestra
et
al
meyer
et
al
pagtalunan
et
al
disappear
associ
worsen
glomerular
injuri
yu
et
al
kidney
express
fulli
function
local
ra
capabl
produc
angii
bader
et
al
paul
et
al
activ
hyperglycem
condit
konoshita
et
al
express
identifi
renal
cortic
tubul
ye
et
al
apic
border
proxim
convolut
tubul
mice
coloc
podocyt
specif
marker
schmid
et
al
nephrin
podocin
synaptopodin
electron
microscopi
confirm
primarili
locat
podocyt
express
kidney
studi
model
dbdb
mice
model
earli
express
elev
ace
express
decreas
glomeruli
cortex
ye
et
al
prior
develop
diabet
nephropathi
similarli
streptozotocininduc
diabet
mice
model
protein
express
elev
earli
decreas
late
tikelli
et
al
phase
diabet
nephropathi
addit
human
ace
express
increas
express
decreas
tubul
diabet
nephropathi
mizuiri
et
al
decreas
express
associ
increas
albuminuria
tikelli
et
al
pharmacolog
inhibit
increas
urinari
albumin
excret
model
soler
et
al
ye
et
al
treatment
exacerb
mesangi
matrix
expans
vascular
thick
soler
et
al
also
caus
focal
loss
podocyt
streptozotocininduc
diabet
mice
indic
may
requir
podocyt
mainten
final
two
model
streptozotocin
akita
mous
model
gene
delet
acceler
develop
diabet
kidney
diseas
wong
et
al
tikelli
et
al
akita
mice
genet
model
reduc
activ
without
evid
insul
yoshioka
et
al
interestingli
gene
delet
akita
mous
background
cross
akita
knockout
mice
result
increas
albuminuria
well
fibronectin
smooth
muscl
actin
express
compar
diabet
mice
intact
wong
et
al
hand
streptozotocininduc
diabet
mice
gene
delet
inhibit
benefici
effect
ace
inhibitor
tikelli
et
al
diabet
nephropathi
suggest
ace
inhibit
potenti
activ
arb
therapi
howev
reduc
albuminuria
mice
wong
et
al
interestingli
ang
administr
also
worsen
diabet
kidney
injuri
streptozotocininduc
diabet
indic
effect
may
mediat
loss
angii
rather
via
ang
shao
et
al
current
find
suggest
may
particip
compensatori
mechan
diabet
kidney
prior
onset
diabet
nephropathi
inde
sever
studi
demonstr
loss
inhibit
exacerb
diabet
nephropathi
soler
et
al
wong
et
al
tikelli
et
al
moreov
local
podocyt
earli
develop
diabet
indic
may
protect
podocyt
loss
thu
prevent
worsen
glomerular
injuri
yu
et
al
confirm
import
target
futur
studi
diabet
kidney
diseas
express
tikelli
et
al
ang
chappel
et
al
identifi
rat
canin
endocrin
pancrea
diabet
zucker
fatti
rat
genet
model
character
obes
hyperglycemia
reduc
insulin
sensit
secret
clark
et
al
protein
mrna
express
elev
acini
islet
correl
increas
ace
collagen
iv
level
tikelli
et
al
although
mice
diabet
observ
signific
increas
fast
blood
glucos
male
vs
p
femal
vs
p
mice
compar
litterm
fig
howev
signific
differ
bodi
weight
comparison
litterm
vs
p
also
observ
ma
receptor
express
pancrea
decreas
mice
fig
therefor
ang
may
potenti
influenc
islet
function
modul
blood
flow
inhibit
fibrosi
via
modul
releas
islet
blood
flow
enhanc
increas
function
demand
due
glucos
infus
styrud
et
al
obes
atef
et
al
pancreatectomi
jansson
sandler
diabet
carlsson
et
al
carlsson
et
al
notabl
enhanc
islet
perfus
accompani
increas
islet
capillari
bp
gotokakizaki
rat
model
carlsson
et
al
alter
islet
blood
flow
associ
abnorm
secret
glucagon
samol
stagner
insulin
atef
et
al
regul
basal
carlsson
et
al
glucosemedi
islet
blood
flow
moldovan
et
al
elev
level
diabet
may
lead
increas
ang
level
islet
could
result
vasodil
stimul
releas
portsi
et
al
heitsch
et
al
accordingli
increas
ang
stimul
signal
would
potenti
mechan
increas
islet
blood
flow
seen
angii
well
known
proinflammatori
suzuki
et
al
profibrot
action
mezzano
et
al
weber
et
al
sever
studi
demonstr
abil
inhibit
effect
diseas
state
diezfreir
et
al
huentelman
et
al
paizi
et
al
herath
et
al
addit
play
import
role
develop
islet
dysfunct
loss
islet
morpholog
donath
et
al
one
potenti
caus
pancreat
failur
johnson
et
al
implic
develop
fibrosi
mani
diseas
state
branton
kopp
express
elev
islet
mice
tikelli
et
al
yamamoto
et
al
hand
ra
blockad
decreas
express
islet
associ
improv
islet
morpholog
function
tikelli
et
al
effect
preserv
islet
architectur
investig
combin
evid
effect
inhibit
fibrosi
diezfreir
et
al
huentelman
et
al
abil
enzym
reduc
express
model
cardiac
fibrosi
grobe
et
al
suggest
inhibit
express
may
prevent
islet
fibrosi
loss
islet
function
studi
effect
ang
glucos
metabol
liver
identifi
hepatocyt
paizi
et
al
along
ra
compon
elev
hepat
fibrogen
diseas
paizi
et
al
herath
et
al
ma
receptor
express
also
identifi
liver
elev
biliari
fibrosi
herath
et
al
express
also
elev
hypox
condit
liver
paizi
et
al
support
potenti
compensatori
role
carboxypeptidas
although
mrna
also
identifi
white
adipos
tissu
galvezprieto
et
al
gembardt
et
al
physiolog
implic
observ
studi
santo
et
al
howev
recent
report
effect
ma
receptor
defici
metabol
ang
bind
gproteincoupl
ma
receptor
santo
et
al
shown
inhibit
angii
respons
da
costa
goncalv
et
al
tallant
et
al
sampaio
et
al
ma
knockout
ma
mice
exhibit
mani
common
featur
metabol
syndrom
aforement
risk
factor
differ
bodi
weight
food
intak
ma
mice
elev
leptin
insulin
level
increas
epididym
retroperiton
fat
mass
addit
mice
dyslipidem
exhibit
elev
serum
muscl
triglycerid
blood
cholesterol
level
ma
mice
also
exhibit
impair
insulin
sensit
glucos
toler
reduc
adipos
glucos
uptak
impair
glucos
transport
express
studi
clearli
demonstr
loss
ma
receptor
lead
metabol
dysfunct
implic
ma
receptor
axi
develop
insulin
resist
obes
insulin
resist
associ
impair
endotheliumdepend
insulinmedi
vasodil
laakso
et
al
steinberg
et
al
william
et
al
moreov
obes
insulin
resist
diabet
associ
decreas
exerciseinduc
hyperemia
fossum
et
al
frisbe
xiang
et
al
exerciseinduc
muscl
glucos
uptak
utriainen
et
al
peltoniemi
et
al
glucos
transport
blood
skelet
muscl
shown
major
impedi
skelet
muscl
glucos
uptak
fueger
et
al
baron
et
al
well
known
ang
potenti
bradykininmedi
vasodil
paula
et
al
lima
et
al
loss
ang
potenti
bradykininmedi
vasodil
rescu
chronic
acut
insulin
oliveira
et
al
rastelli
et
al
oliviera
et
al
demonstr
ang
potenti
bradykinin
depend
instead
voltag
gate
k
channel
oliveira
et
al
rastelli
et
al
show
k
channel
prostanoid
influenc
pathway
rastelli
et
al
addit
modul
vasodil
bradykinin
signal
increas
transloc
kishi
et
al
glucos
uptak
skelet
muscl
adipos
tissu
beard
et
al
kishi
et
al
moreov
bradykininmedi
enhanc
glucos
uptak
adipos
tissu
shown
involv
beard
et
al
inde
ace
inhibitor
improv
skelet
muscl
glucos
uptak
bradykininmedi
increas
henriksen
et
al
ang
mediat
potenti
bradykinin
signal
may
also
affect
transloc
glucos
uptak
skelet
muscl
blunt
pathway
may
thu
exacerb
develop
insulin
resist
diabet
hyperact
ra
involv
pathogenesi
diabet
diabet
complic
new
compon
ra
elev
diabet
diabet
nephropathi
may
involv
compensatori
mechan
oppos
aceangii
axi
islet
may
modul
blood
flow
morpholog
order
maintain
insulin
secret
fig
compensatori
effect
diabet
alreadi
suggest
kidney
studi
demonstr
inhibit
worsen
diabet
nephropathi
addit
ang
product
angii
cleavag
mediat
vasodil
therefor
may
enhanc
insulin
sensit
conclus
recent
data
literatur
laboratori
suggest
express
modul
diabet
delet
affect
glucos
homeostasi
sever
transgen
model
alreadi
pipelin
address
role
diabet
metabol
diseas
futur
studi
like
confirm
new
target
treatment
prevent
diabet
complic
anim
model
lack
use
demonstr
role
develop
diabet
diabet
complic
accordingli
breed
akita
mice
alreadi
reveal
import
prevent
diabet
kidney
diseas
wong
et
al
similar
strategi
involv
knockout
mice
diabet
model
could
understand
role
develop
diabet
diabet
complic
addit
huang
et
al
tikelli
et
al
two
inhibitor
shown
effect
reduc
effect
enzym
compound
could
deliv
anim
prior
onset
diabet
demonstr
influenc
ang
develop
diabet
diabet
complic
enhanc
pharmacolog
genet
intervent
also
attract
option
prevent
treatment
diabet
diabet
complic
ferreira
et
al
recent
demonstr
efficaci
pharmacolog
activ
among
dimethylamino
ethyl
amino
hydroxymethyl
sulfonyl
oxi
xnt
capabl
reduc
cardiac
fibrosi
high
blood
pressur
spontan
hypertens
rat
ferreira
raizada
final
viral
deliveri
therefor
overexpress
shown
reduc
angiimedi
respons
feng
et
al
huentelman
et
al
addit
modul
direct
target
ang
also
possibl
end
ang
receptor
antagonist
dala
ang
santo
et
al
ang
analogu
ave
wiemer
et
al
avail
recent
shao
et
al
demonstr
ang
infus
worsen
diabet
kidney
diseas
seem
oppos
idea
benefici
diabet
kidney
diseas
shao
et
al
find
highlight
need
studi
ang
signal
pathway
potenti
effect
combin
differ
strategi
could
help
discrimin
effect
ang
gener
activ
develop
diabet
clarifi
role
ma
receptor
axi
fastprogress
diseas
role
ra
metabol
organ
function
angii
signal
cascad
inhibit
insulin
releas
decreas
insulin
sensit
ra
blockad
improv
glucos
homeostasi
reduc
death
improv
insulin
secret
endorgan
insulin
sensit
hypothet
model
role
pancrea
angii
known
decreas
islet
blood
flow
increas
islet
oxid
stress
caus
apoptosi
decreas
insulin
secret
red
arrow
emphas
hyperglycemiainduc
chang
islet
ra
consequ
inhibit
may
reduc
amyloid
deposit
islet
fibrosi
subsequ
apoptosi
ang
mediat
vasodil
may
lead
increas
blood
flow
combin
reduct
apoptosi
increas
islet
blood
flow
could
caus
increas
insulin
secret
preserv
islet
function
diabet
green
arrow
highlight
hypothet
pathway
may
influenc
islet
function
